Trade Summary

1 week ago, Cavanagh Bethany J, serving as SVP, Finance, Treasurer at Beam Therapeutics Inc. (BEAM), sold 3,242 shares at $24.58 per share, for a total transaction value of $79,688.00. Following this transaction, Cavanagh Bethany J now holds 51,171 shares of BEAM.

This sale represents a 6.00% decrease in Cavanagh Bethany J's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 5 days after the trade was made.

Beam Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.